HUT56494A - Process for producing pharmaceutical compositions suitable for peroral administration of pimobendane - Google Patents

Process for producing pharmaceutical compositions suitable for peroral administration of pimobendane

Info

Publication number
HUT56494A
HUT56494A HU91177A HU17791A HUT56494A HU T56494 A HUT56494 A HU T56494A HU 91177 A HU91177 A HU 91177A HU 17791 A HU17791 A HU 17791A HU T56494 A HUT56494 A HU T56494A
Authority
HU
Hungary
Prior art keywords
pimobendane
pharmaceutical compositions
compositions suitable
peroral administration
producing pharmaceutical
Prior art date
Application number
HU91177A
Other languages
English (en)
Other versions
HU207948B (en
HU910177D0 (en
Inventor
Peter Gruber
Willy Roth
Gottfried Schepky
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of HU910177D0 publication Critical patent/HU910177D0/hu
Publication of HUT56494A publication Critical patent/HUT56494A/hu
Publication of HU207948B publication Critical patent/HU207948B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU91177A 1990-01-20 1991-01-18 Process for producing oral pimobendane compositions HU207948B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4001622A DE4001622A1 (de) 1990-01-20 1990-01-20 Orale arzneimittelformen von pimobendan

Publications (3)

Publication Number Publication Date
HU910177D0 HU910177D0 (en) 1991-08-28
HUT56494A true HUT56494A (en) 1991-09-30
HU207948B HU207948B (en) 1993-07-28

Family

ID=6398467

Family Applications (1)

Application Number Title Priority Date Filing Date
HU91177A HU207948B (en) 1990-01-20 1991-01-18 Process for producing oral pimobendane compositions

Country Status (18)

Country Link
EP (1) EP0439030B1 (hu)
JP (1) JP2608183B2 (hu)
KR (1) KR0163056B1 (hu)
AT (1) ATE87481T1 (hu)
AU (1) AU630536B2 (hu)
CA (1) CA2034569C (hu)
DE (2) DE4001622A1 (hu)
DK (1) DK0439030T3 (hu)
ES (1) ES2054379T3 (hu)
FI (1) FI96274C (hu)
HK (1) HK175796A (hu)
HU (1) HU207948B (hu)
IE (1) IE64659B1 (hu)
IL (1) IL96995A (hu)
NO (1) NO176305C (hu)
NZ (1) NZ236834A (hu)
PT (1) PT96506B (hu)
ZA (1) ZA91372B (hu)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
DE102004011512B4 (de) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
EP1744750A2 (en) * 2004-05-06 2007-01-24 Sandoz AG Pharmaceutical composition comprising hydrophobic drug having improved solubility
WO2005123040A1 (ja) * 2004-06-22 2005-12-29 Shionogi & Co., Ltd. 口腔内速崩壊錠
JP4572296B2 (ja) * 2004-07-21 2010-11-04 トーアエイヨー株式会社 ピモベンダン経口投与製剤
JP4572293B2 (ja) * 2004-07-21 2010-11-04 トーアエイヨー株式会社 ピモベンダン経口投与製剤
JP2006028130A (ja) * 2004-07-21 2006-02-02 Toa Eiyo Ltd ピモベンダン経口投与製剤
US20070105867A1 (en) * 2005-09-21 2007-05-10 Bristol-Myers Squibb Company Oral administration of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof
JP4572300B2 (ja) * 2006-01-19 2010-11-04 トーアエイヨー株式会社 ピモベンダン経口投与製剤
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
PE20081482A1 (es) * 2006-12-20 2008-12-23 Novartis Ag Capsulas de gelatina que contienen un acido
FR2934156B1 (fr) 2008-07-23 2010-09-24 Virbac Medicament appetissant a administration orale sous forme solide
WO2010055119A2 (en) * 2008-11-17 2010-05-20 Novartis Ag Pharmaceutical composition comprising pimobendan
PL2370070T3 (pl) 2008-11-25 2014-02-28 Boehringer Ingelheim Vetmedica Gmbh Pimobendan do zastosowania w leczeniu kardiomiopatii przerostowej u kotów
NL1037569C2 (en) 2009-12-18 2011-06-21 Eurovet Animal Health B V Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use.
KR20120116422A (ko) * 2009-12-29 2012-10-22 코와 가부시키가이샤 경구 투여용 의약 조성물
WO2011081117A1 (ja) * 2009-12-29 2011-07-07 興和株式会社 経口投与用固形医薬組成物
HUE060093T2 (hu) 2012-03-15 2023-01-28 Boehringer Ingelheim Vetmedica Gmbh Gyógyszerészeti tablettakészítmény az állatgyógyászati ágazat számára, eljárás annak elõállítására és annak alkalmazása
PL3021832T3 (pl) 2013-07-19 2021-08-23 Boehringer Ingelheim Vetmedica Gmbh Konserwowana ciekła wodna kompozycja farmaceutyczna zawierająca eteryfikowane pochodne cyklodekstryny
DK2925305T3 (en) * 2013-12-04 2016-10-10 Boehringer Ingelheim Vetmedica Gmbh Improved pharmaceutical compositions of pimobendan.
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
CN106729723A (zh) * 2016-11-21 2017-05-31 青岛农业大学 一种含匹莫苯丹的药物组合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2837161A1 (de) * 1978-08-25 1980-03-06 Thomae Gmbh Dr K Neue benzimidazole und deren verwendung
ES482789A0 (es) * 1978-08-25 1980-12-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona
JPS56110612A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Readily disintegrable and absorbable compression molded article of slightly soluble drug
JPS60163823A (ja) * 1984-02-03 1985-08-26 Taisho Pharmaceut Co Ltd 経口投与製剤
ATE71833T1 (de) * 1986-11-03 1992-02-15 Schering Corp Labetalol tablette mit verzoegerter wirkstoffabgabe.
DE3728244A1 (de) * 1987-08-25 1989-03-09 Thomae Gmbh Dr K Neue (-)-benzimidazole, deren herstellung und diese verbindungen enthaltende arzneimittel
EP0306846A3 (de) * 1987-09-11 1990-05-02 Dr. Karl Thomae GmbH Neue synergistische Kombination bestehend aus einem Phosphodiesterase-Hemmer und einem Thromboxan-A2-Antagonisten und deren Verwendung bzw. Herstellung
DE3805635A1 (de) * 1988-02-24 1989-09-07 Thomae Gmbh Dr K Verwendung von benzimidazolen zur herstellung eines arzneimittels mit antiischaemischen wirkungen am herzen und dessen kombinationen mit ss-blockern oder bradycardica
JPH01258621A (ja) * 1988-04-06 1989-10-16 Fujimoto Seiyaku Kk 吸収が調節されたジラゼプ錠
JPH023609A (ja) * 1988-06-21 1990-01-09 Fujimoto Seiyaku Kk 塩酸ニカルジピンを活性成分とする持効性製剤

Also Published As

Publication number Publication date
NO910213D0 (no) 1991-01-18
IE64659B1 (en) 1995-08-23
HU207948B (en) 1993-07-28
JPH04210919A (ja) 1992-08-03
FI910263A0 (fi) 1991-01-18
NO910213L (no) 1991-07-22
JP2608183B2 (ja) 1997-05-07
HK175796A (en) 1996-09-27
IE910165A1 (en) 1991-07-31
EP0439030B1 (de) 1993-03-31
DE59100067D1 (de) 1993-05-06
IL96995A (en) 1994-11-11
DK0439030T3 (da) 1993-08-16
NO176305B (no) 1994-12-05
ATE87481T1 (de) 1993-04-15
ZA91372B (en) 1992-09-30
NZ236834A (en) 1995-10-26
PT96506A (pt) 1991-10-15
FI96274C (fi) 1996-06-10
FI96274B (fi) 1996-02-29
AU6945491A (en) 1991-07-25
FI910263A (fi) 1991-07-21
DE4001622A1 (de) 1991-07-25
EP0439030A2 (de) 1991-07-31
AU630536B2 (en) 1992-10-29
NO176305C (no) 1995-03-15
KR910014120A (ko) 1991-08-31
KR0163056B1 (ko) 1998-12-01
HU910177D0 (en) 1991-08-28
ES2054379T3 (es) 1994-08-01
PT96506B (pt) 1998-06-30
CA2034569A1 (en) 1991-07-21
IL96995A0 (en) 1992-03-29
CA2034569C (en) 2002-03-19
EP0439030A3 (en) 1991-10-16

Similar Documents

Publication Publication Date Title
HUT56494A (en) Process for producing pharmaceutical compositions suitable for peroral administration of pimobendane
HUT62466A (en) Process for producing locally applicable pharmaceutical compositions comprising allylamine derivatives, against fungus infection
HUT59591A (en) Process for producing solide, oral retarde pharmaceutical compositions
HUT67653A (en) Nor-bile-acid derivatives, process for producing them and pharmaceutical compositions containing them
HUT48266A (en) Process for producing 2,3'-dideoxy-2'-fluoronukleozides and pharmaceutical compositions containing them as active componenets
AU688803B2 (en) Method for treatment for pulmonary disease
IT1255792B (it) Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda
DE3566545D1 (en) 2-substituted-1,3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them
HUT65626A (en) Process for producing of acridinedione derivatives and pharmaceutical compositions comprising them
ATE236620T1 (de) Zusammensetzungen mit langsamer freigabe enthaltend eine zinkverbindung und vitamin c- derivate
ZA949332B (en) Use of 1-{4-[4-aryl(or heteroaryl)-1-piperazinyl]-butyl}-1H-azole derivatives for the preparation of medicaments intended for the treatment of disorders of gastric secretion
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
NZ232388A (en) Thioether derivatives of aminoalkoxyphenyl compounds and pharmaceutical compositions
ATE99946T1 (de) Lagerstabile orale glucosaminsulfat-dosisformen und verfahren zu deren herstellung.
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
AU1123183A (en) Pyridobenzodiazepinone derivatives
DE69009765D1 (de) Kynurensäurederivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ZA918023B (en) Novel p-oxybenzoic acid derivatives,process for the preparation thereof and use thereof as drug
HU904983D0 (en) Process for producing imidazo(5,1-b)quinazoline-9-one derivatives and their pharmaceutically acceptible salts as well as process for producing pharmaceutical preparatives containing these active substances
HU207316B (en) Process for producing octahydro-indolo/2,3-a/quinolyzinepphenyl-sulfonamide derivatives, acid additional salts thereof and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee